Dr. George evaluates BTK inhibitors and provides an overview of the clinical trials
Dr. George Follows, UK
Dr. George Follows, a Consultant Haematologist at Cambridge University Hospitals and Professor of Haematology at Anglia Ruskin Medical School, discusses the critical evaluation of BTK inhibitors (BTKis) for the treatment of CLL and discussed its overall outcomes in CLL and relapsed CLL, as well as toxicity considerations.
Explore more videos
Translating Data Into Clinical Practice
Dr. Abdulkareem Algarni, KSA
Evolvement of CLL Management
Dr. Mahmoud Marashi, UAE
CLL Management Inside the Clinic
Dr. Hani Yousif Osman , UAE